Suppr超能文献

对速效胰岛素的需求。

The Need for Faster Insulin.

作者信息

Muchmore Douglas B

机构信息

1 Kinexum Services, La Jolla, CA, USA.

出版信息

J Diabetes Sci Technol. 2017 Jan;11(1):157-159. doi: 10.1177/1932296816677577. Epub 2016 Nov 10.

Abstract

Considerable progress in treatment of diabetes has been made in the nearly 100 years following the discovery of insulin, and advances in insulin therapy have improved convenience, quality of life, overall glycemic control (A1C), and risk of hypoglycemia. An unmet need remains for a mealtime insulin that can faithfully reproduce the metabolic profile that ensues following meal ingestion in healthy persons. A number of "ultra-fast" insulin programs have been initiated, and Afrezza® (insulin human; Inhalation Powder, MannKind Corporation, Danbury, CT) stands as the first such product to be approved by the US FDA. Afrezza is unique as an "ultra-ultra" fast insulin, faster than any other entrant except IV insulin. The benefits and limitations of the Afrezza profile are discussed in this analysis.

摘要

自胰岛素被发现后的近100年里,糖尿病治疗取得了显著进展,胰岛素治疗的进步提高了便利性、生活质量、总体血糖控制(糖化血红蛋白)以及低血糖风险。对于一种能够忠实地重现健康人进食后代谢情况的餐时胰岛素,仍存在未满足的需求。已经启动了一些“超快”胰岛素项目,而Afrezza®(人胰岛素;吸入粉,曼金德公司,康涅狄格州丹伯里)是首个获美国食品药品监督管理局批准的此类产品。Afrezza作为一种“超超快”胰岛素独具特色,其起效速度比除静脉注射胰岛素外的任何其他同类产品都要快。本分析将探讨Afrezza的优缺点。

相似文献

1
The Need for Faster Insulin.对速效胰岛素的需求。
J Diabetes Sci Technol. 2017 Jan;11(1):157-159. doi: 10.1177/1932296816677577. Epub 2016 Nov 10.
3
A second-generation inhaled insulin for diabetes mellitus.一种用于糖尿病的第二代吸入式胰岛素。
Am J Health Syst Pharm. 2015 Jul 15;72(14):1181-7. doi: 10.2146/ajhp140540.
5
Afrezza: An inhaled approach to insulin delivery.阿夫雷扎:一种吸入式胰岛素给药方法。
J Am Assoc Nurse Pract. 2015 Oct;27(10):597-601. doi: 10.1002/2327-6924.12247. Epub 2015 Mar 12.
9
Inhaled insulin: a breath of fresh air? A review of inhaled insulin.吸入式胰岛素:一股清新之风?吸入式胰岛素综述
Clin Ther. 2014 Aug 1;36(8):1275-89. doi: 10.1016/j.clinthera.2014.06.025. Epub 2014 Jul 17.
10
Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.一种新型吸入式胰岛素的药代动力学和药效学特性
J Diabetes Sci Technol. 2017 Jan;11(1):148-156. doi: 10.1177/1932296816658055. Epub 2016 Jul 9.

引用本文的文献

5
Type 1 diabetes.1 型糖尿病。
Lancet. 2018 Jun 16;391(10138):2449-2462. doi: 10.1016/S0140-6736(18)31320-5.
6
Inhaled Insulin: Dead Horse or Rising Phoenix?吸入式胰岛素:死马还是浴火重生的凤凰?
J Diabetes Sci Technol. 2018 Mar;12(2):239-242. doi: 10.1177/1932296817748231. Epub 2017 Dec 13.

本文引用的文献

1
Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.一种新型吸入式胰岛素的药代动力学和药效学特性
J Diabetes Sci Technol. 2017 Jan;11(1):148-156. doi: 10.1177/1932296816658055. Epub 2016 Jul 9.
5
Ultrafast-acting insulins: state of the art.速效胰岛素:最新进展
J Diabetes Sci Technol. 2012 Jul 1;6(4):728-42. doi: 10.1177/193229681200600402.
9
Basal and 24-h C-peptide and insulin secretion rate in normal man.
Diabetologia. 1987 Jan;30(1):16-21. doi: 10.1007/BF01788901.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验